Leukemia Clinical Trials in Austin

Showing 1061-1080 of 1,100 trials

Repeat-Dose of Forodesine Hydrochloride (BCX-1777) Infusion in Patients With Advanced T-Cell Leukemia

NCT00095381

BCX-1777 may stop the growth of cancer cells by blocking the enzymes necessary for their growth. The Phase II trial is designed to study the effectiveness of BCX-1777 in treating patients who have recurrent or refractory advanced T-cell leukemia. Patients will receive an infusion of BCX-1777 on days 1-5. Treatment may be repeated every week for up to six courses. Patients are not required to be hospitalized for the administration of BCX-1777. Some patients may continue to receive an infusion of BCX-1777 twice a week for 6 weeks.

Leukemia, T-Cell

BioCryst Pharmaceuticals20 participantsStarted Mar 2004

Los Angeles, California, United States • Palo Alto, California, United States • Denver, Colorado, United States +21 more locations

COMPLETEDPhase 2< 1 mile

A Pilot Study of OSI-461 in Patients With Chronic Lymphocytic Leukemia (CLL)

NCT00073489

The objectives of this study are to evaluate the safety and efficacy of OSI-461 in CLL patients.

Chronic Lymphocytic Leukemia

Astellas Pharma Inc23 participantsStarted May 2001

Phoenix, Arizona, United States • Aurora, Colorado, United States • Jacksonville, Florida, United States +12 more locations

Repeat-Dose of Forodesine Hydrochloride (BCX-1777) Infusion in Patients With Advanced T-Cell Leukemia

A Pilot Study of OSI-461 in Patients With Chronic Lymphocytic Leukemia (CLL)

Leukemia Trials in Other Cities

Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases

Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer

Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy.

Trial of STAHIST in Seasonal Allergic Rhinitis

Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia

Safety Study of XL999 in Adults With Non-Small-Cell Lung Cancer

Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma

Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Docetaxel in Platinum-Resistant Non-Small Cell Lung Cancer

Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung Cancer

Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors

A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC

Study of XIAP Antisense Given With Chemotherapy for Refractory/Relapsed AML

Study of XL281 in Adults With Solid Tumors

Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study

Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer

Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer

A Study of Nimotuzumab in Combination With External Radiotherapy in Non-Small Cell Lung Cancer

Safety/Efficacy Study of Immunoconjugate With Docetaxel in Non-small Cell Lung Carcinoma

Other Conditions in Austin